Instrument Inactif

Autres langues Orthovita, Inc.

Actions

Equipement, fournitures et distribution médicale

Cours en clôture Nasdaq
- ^USD	-

Autres langues

21/05/11	ORTHOVITA : Law Office of Brodsky & Smith, LLC Announces Investigation of Orthovita, Inc.
17/05/11	ORTHOVITA : The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Orthovita, Inc. in Connection with the Sale of the Company to Stryker Corporation -- VITA
16/05/11	ORTHOVITA : The Briscoe Law Firm Investigates Orthovita, Inc. for Shareholders Concerning Acquisition by Stryker Corporation
16/05/11	ORTHOVITA : The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Orthovita, Inc. in Connection with the Sale of the Company to Stryker Corporation -- VITA
16/05/11	ORTHOVITA : Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of Orthovita, Inc.
16/05/11	ORTHOVITA : Orthovita, Inc. Agrees To Be Acquired by Stryker Corporation for $3.85 Per Share in Cash
11/05/11	ORTHOVITA : Notes Noridian, a Medicare Contractor, Issues Future Local Coverage Decision Covering Vertebroplasty and Vertebral Augmentation
10/05/11	ORTHOVITA : to Present at the Bank of America Merrill Lynch Health Care Conference
04/05/11	ORTHOVITA : Reports 2011 First Quarter Financial Results
19/04/11	ORTHOVITA : Schedules First Quarter 2011 Financial Results Conference Call
13/04/11	ORTHOVITA : Launches the Aliquot Directional Bone Tamp
11/04/11	ORTHOVITA : Announces Presentation of Clinical Results Evaluating Vitagel? Surgical Hemostat in Reducing Blood Loss During Primary Unilateral Total Knee Arthroplasty
08/03/11	ORTHOVITA : Reports 2010 Fourth Quarter and Year-End Financial Results and Provides 2011 Financial Guidance
16/02/11	ORTHOVITA : Launches Vitoss? Bioactive Foam-2X Bone Graft Substitute at AAOS (American Academy of Orthopedic Surgeons) Meeting
14/02/11	ORTHOVITA : Schedules Conference Call for Fourth Quarter and Year-End 2010 Financial Results and 2011 Guidance
10/02/11	ORTHOVITA : Receives FDA Clearance for Vitoss? Bimodal Bone Graft Substitute
08/02/11	ORTHOVITA : to Present at the Canaccord Genuity Musculoskeletal Conference
15/12/10	ORTHOVITA : to Present at the J.P. Morgan 29th Annual Healthcare Conference
07/12/10	ORTHOVITA : Receives FDA Clearance for Vitoss? Bioactive Foam-2X Bone Graft Substitute
17/11/10	ORTHOVITA : to Present at the Piper Jaffray 22nd Annual Health Care Conference
04/11/10	ORTHOVITA : to Present at the Maxim Group 4th Annual Growth Conference
02/11/10	ORTHOVITA : Reports 2010 Third Quarter Financial Results And Updates Full Year Financial Guidance
01/11/10	ORTHOVITA : to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
25/10/10	ORTHOVITA : Schedules Third Quarter 2010 Financial Results Conference Call
21/10/10	ORTHOVITA : Kensey Nash Reports First Quarter Fiscal Year 2011 Financial Results